dear shareviews i feel FOOL is not so bad when you compare with the vocabulary of certain MMB boarders. Rightly you said: PSTL CANNOT BE COMPARED TO PYRAMID- (pyramid is a egg shell) if you want to take a risk- take your risk at 7.00 to 9.00 and ready to write off or hang on. IT IS LIKE A LOTTERY- Basically there is nothing. (now sami has given a small halwa- free shares of production company) The main purpose of the production company take over is to siphon funds without any obstacle in a legal way. Cheers ...

thanks for info and i think i am taken for a ride by my broker. TODAY LET ME STRIP HIM. I have to absorb the moral responsibility of your depreciation in binny. But - you can certainly see some lime light. PLEASE DONOT AVERAGE...

Forgot to mention. I bought on line only and paid only the market price....

Dear This is not traded in electronic form if i am right (as per my broker knowledge) I will be thankful if you could confirm whether YOU PURCHASED ONLINE. My broker is running around to get the shares even today. I DO NOT KNOW WHETHER I AM TAKEN FOR A RIDE. I need a small help from you. If you can confirm whether you purchased IN ELECTRONIC FORM OR PAPER COPY TRNASFERRED. I am still behind it and I am ending up by paying more than 30 percent as premium to my broker. Your assistance is highly appreciated. You can also share your broker name TO MY PM. Thanks for your assistance. ONE THING: SHARE HAS IMMENSE VALUE. There is no doubt about it. alteast WORTH TAKING RISK ...

just can`t stop laughing...jindal photo, photo of jindal...ha ha hahahha...

Hi May be Marketman is an ex-employee of INFY who had some specific problems with INFY mangement. Or even he may be the poodle of some FIIs to help them to get INFY shares at a lower rate. Inestors need to invest based on financial parameters like profitability, P/E ratio and cash flow etc...NOT on advise of somebody in open forum like MMB. Here any one can post message as long as its not abusive on someone. So if someone is investing based on the advises given in MMB are stupids........

SHAREVIEWS, Are you asking this question cum-bonus or ex-bonus by 2011?...

DD the Tiger only expressed his anger on those who recommended this stock, because he bought it and incurred heavy loss. There is no Comparison of PSTL with Satyam. Suggest to keep away from this counter and we have thousands of good stocks other than PSTL to select from. ...

marketman, Pls visit PSTL board and let us have your valuable comments....

Dont worry. You are not forcing anyone to buy. ...

Binny Ltd.
514215 BINNY Group (T) BSE data

If this is the stock you all are talking about, I confirm having bought on line. I am confused why people are giving offers for off-market purchase. ...

Forgot to mention. I bought on line only and paid only the market price....

Dear Pitquote, It was only becuase I have seen you in this board, I bought this stock. Now I am in 40% loss. No worries. This stock I bought through Geojit. There was absolutely no problem and it is bought like any other stock. It is in my demat a/c. I think you are taken for a ride....

Dear pitquote, Stock moving in LC for the past three days. As per your msg I understand that people are ready to buy the shares even from grey market. But if it is in so high demand, how come no buyer situation comes, even when a few hundred shares are not absorbed. From the day when I bought 100 shares it started moving down. But I dont mind holding it and adding more. Pls comment....

Following information taken from a pre IPO analysis in May 2008.
Quote:-
Anu’s Laboratories, Started in Hyderabad in 1996 by K. Hari Babu, Anu’s Laboratories e manufactures basic and advanced intermediates and fine chemicals. Some of the key intermediates produced are 2,4-dichloro-5-fluoro acetophenone (DCFA) (an intermediate for synthesising quinolone antibiotics like ciprofloxacin), chlorohexanone (key intermediate in the manufacture of cardio vascular medicine), methyl-4 (4-chloro, 1 oxo butyl),and di-methyl acetate (an intermediate used to manufacture Fexofenadine, an anti allergic drug). These three intermediates accounted for around 29%, 24% and 9% of the company’s sales in the nine months ended December 2007. Exports to Israel, Italy, Japan, France, USA and Singapore accounted for around 20% of the sales in this period.

As a forward-integration measure, Anu’s Laboratories has proposed setting up a plant for manufacturing drug intermediates including active pharma ingredients (APIs) at Jawaharlal Nehru Pharma City, Vishakhapatnam, Andhra Pradesh, for Rs 55.09 crore. Land measuring 9.54 acres has been purchased by paying an initial sum of Rs 0.91 crore. A separate development-cum-service agreement for development of this land has been entered with Andhra Pradesh Industrial Infrastructure Corporation (APIIC) and Ramky Pharma City (Ramky). Commercial operations are expected by April 2009.

To bolster its contract research and manufacturing (CRAMS) & R&D operations, Anu’s Laboratories is to set up a pilot plant at Jawaharlal Nehru Pharma City for Rs 8.34 crore. From the IPO proceeds, Rs 16.67 crore is to be earmarked for meeting long-term working capital requirement.

From internal accruals, Rs 12 crore will be deployed for the expansion programme and meeting issue expenses. By 7 April 2008, Rs 1.29 crore had been utilised.

Weaknesses

Around 53% of the revenue was from the sale of two products: DCFA and CIS Lactum in the nine months ended December 2007. Any decline in the sales of these products or potential substitute or volatility in the prices of these products may adversely affect the financial performance.

Dr. Reddy’s Laboratories accounted for around 47% of the revenue.

About 34% of the sales were from products manufacturing, outsourced to a promoter group company, Nitya Laboratories. This can lead to conflict of interest. Moreover, Nitya Lab has been incurring losses, has overdues to banks and is involved in various legal proceedings.

Valuation

Anu’s Laboratories has set a price band of Rs 200 to Rs 210 per equity share of Rs 10 face value. At the lower band of Rs 200 per share, the P/E would be 13.8x times annualised EPS of Rs 14.5 for the nine months ended December 2007 and 17.8x times the EPS of Rs 11.3 for the year ending March 2007 (FY 2007) on post-issue equity of Rs 12.08 crore. At the upper band of Rs 210 per share, the P/E would be 14.5x times and 18.7x times, respectively. In the pharmaceutical industry (bulk drug and intermediates), comparable companies such as Neuland Labs, Aarti Drugs and SMS Pharma have TTM P/E of around 9.5, 4.8 and 10.4, respectively.

Unquote:-
Hope above information will be of help to those who want to know more about the Company, before investing.
...

The way market gone up today, many people may think thate volumes and turnover was huge , but on the contarary it was too less and no trading happened in many counters. Just see a few from the sensex pack.
ACC - 2346
AIRTEL - 9219
BHEL- 8419
DLF - 59378
GRASIM - 1327
HDFC - 3232
HDFC BANK - 1687
INFOSYS - 5215
ITC - 5029

As per my thought, those who bought today have invited some risk and those were holding since the past few days are now in an advantageous and these people will try to book profit tomorrow. Hence most probabaly we may see some selling pressure during tomorrow one hour session. However we are witnessing a new scenario at the moment and feel that tomorrow investors will make a cautious approach, because majority investors will be watching the discussions on this topic today and seeking openions from others as to what should be tomorrows strategy. Now the words of caution might have already spread in the market and ofcourse nothing to panic, since everyone is with a positive frame of mind after the results.



...

Why Tanla when we have better options. These targets were given all most one year back and it never achieved those targets even when the markets were bullish. See the fate if this stock, its on pathetic level of Rs. 50....

It may look very interesting for you to see other loosing money. Everybody knows that people stuck in this stock at the moment are genuine investors and they have nothing to do with any manipulations. If SEBI is so concerned, they should investigae and find out the culprits and punish them. Now with this action whose interest is safeguarded ? Such actions are intended for genuine investors not to loose money, but this action did exactly the opposite. All those traders got advance notice to move out of the stock and no one is there with Akruti at this moment. ...

I have just given a suggestion because I really feel very much upset about such silly actions and feel that all investors are fooled by those who are supposed to protect. There were many terrorist acts in our country in the recent past and the Mumbai terror strike was an eye opener and atlest people decided to unite and show their protest against the laxity of the Government in providing adeqate security to the common man. Then everybody realised the seriousness. I am very much sure that 90% of the investors now stuck in Akruti are straight forward investors/traders and this kind of action is total injustice to those people. Just imagine how stupid it is to see a stock trading with a difference of around 20%in two exchanges and no one bothered to correct it. Let them re-list it if they want and let off of us loose full in a day and it is better than killing people inch by inch. All those culprits alleged to be involved in price manipualtion shoudl have been out safely from Akruti and may be having a nice time in other counters like Educomp. Even if investors unite or not, I am not concerned, because I have my own action plans. I very well know we are in a country where people have no unity at all. Investors should express their difficulties if any such an action hurt them in such a way like what is now happening in Akruti. If there was no circuits fixed, the stock might have been trading smoothly and F&O aan was adequate for the tiem being....